Figure 4.
CD19 B-cell counts after rituximab therapy. (A) Randomized controlled trial of drug-dependent nephrotic syndrome. (B) Single-arm study of drug-resistant nephrotic syndrome.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.